i know there are lots of people who are feeling bad seeing SRNE down from the prior high last week and seeing this pullback isn't fun. however, similar to many of the prior pullbacks(i've been in this stock a long time), whether from $5 to $3 or $12 to $8, or even $26 to $19ish, when you look back later this year and the stock's at $30+, this will just be "noise."
do your own work and know what you own - that's the best defense against thieves who try to steal shares from you w/ these drops. after all, i did my own work on QCOR and MNK, and it has taught me to value of not getting caught up in the noise - that's the only way to get 5 to 10-baggers.
Einhorn also loaded up on Micron before the last drop...looks like he doesn't realize that he's the fool at the poker table. after all, if you take out his AAPL holdings(which anyone can own w/o paying him 20% profits), not sure he's added ANY value vs. just putting money in index fund or MNK :)
imho, bear raid already occurred and MNK will rally going into earnings as shorts (slowly) figure out the company will likely beat and guide up earnings again :)
congrats to all those who are already on board.
be sure to do your own work and watch the ipo roadshow of NK on youtube.
imho, this stock could be $40-50+ for patient holders.
imho, first day performance is not that important. find the right company and you'll get an even higher return, i.e.. Tencent QCOR VIPS - many of these were 100-baggers that you could buy ALL DAY LONG.
yep, this is similar to the roadshow that PSS did at the IPO mtg Friday in SF, except that he is much more dynamic in person, plus there's another 10-15 minutes of Q&A with the fund mgrs.
bottom line, this is a gigantic market cap to market opportunity story for NK, and since most IPO buyers will be shut out at the initial pricing, probably the best way to play NK might be to buy more SRNE. otherwise, just buy NK on the first trading day at $4-5B+ mkt cap, and watch it possibly go to $100-200B+ over time. Or...just buy SRNE now and you'll have a nice piece of NK.
mikey has ALWAYS said don't do what he does - he has his reasons/asset allocations, plus he is not always right(as he admits). everyone should do their own work, but imho, MNK is a $200+ stock in disguise(mini-VRX)...and the patient holder will be well rewarded :)
glad you're involved.
i don't give reco, but imho, if don't own any srne, just buy some to be involved and wait for pullback to add.
my price tgt is $35-40+ s-term, but i think l-term it could be a $100+ stock.
heading to SF IPO roadshow soon...good luck!
the IPO is done and the roadshow is just a formality for people to meet PSS.
NK already did 13 "practice" mtgs earlier and this is a tiny deal w/ good chunk of deal already spoke for, and probably a tiny float after all the big funds get their chunks.
bottom line, this is meant for a coming out party for PSS for the world to know that PSS wants to be the biggest name in healthcare.
cramer is a bozo and is there for entertainment purposes.
many people have made LOTS of $ doing opposite of what he says.
however, at times cramer is in cahoots w/ his HF buddies, particularly on shorts, so be weary of any of this comments on stocks.
bottom line, do your own work!!!
just my 2 cents.
i still LOVE MNK, but if you guys need another name, SRNE is my 2nd largest position(and catching up quickly to MNK).
do your own work, but i compare SRNE today to QCOR at $25 - i think it goes higher, and then will get acquired for big premium.
i've been adding to MNK on the recent pullback and still think this is s $200 stock in disguise.
LOTS of s-term traders out there, but i'm the guy who buys/holds.
yep, unless MNK gets acquired for $200+, i'll likely just keep holding on and enjoy the ride up.
why would MNK go higher?
1) too cheap. p/e is close to 11x for 2016 vs. peer group closer to 20x.
2) too cheap vs sp500, 2x the growth rate at 1/3 less p/e
3) estimates going higher. yep, MNK has track record of being conservative w/ beat/guide up.
4) chart now constructive again - above the 50days ma
5) the sector still strong, and MNK relative strength 90+
6) MNK part of sp500 index, and long only funds must own, or risk underperforming
7) importantly, MNK has cont'd to acquire...expect more to come, and estimates going higher
8) MNK may divest imaging biz, net positive, get cash and better focus on new acquisitions.
9) solid solid mgmt team - funds will eventually figure out
10) lastly, MNK already has suitors just like all growing pharma, but price too low...so going higher.
the S1 was filed this past wknd, and the bankers are planning the IPO roadshow.
note: company has already done some preview mtgs, and w/ IBB at all-time high, hearing that the ENTIRE IPO is already pre-sold - meaning it's just a matter of picking who will get the IPO shares before it pops up 50-100%+, imho.
do you know what this means for SRNE? yippee!
for those who have missed this pre-Conkwest IPO filing, this is actually a BETTER buy at $16 than before at $14 as now you know it's real...looking for $40+ stock on SRNE over the next 12-18 months.
today must be the retail daytrading dummies who sold SRNE down to $8-10...right before it went to $12-14.
this stock is a better buy today in the $13s than it was as $9 - just do your own work, esp on the $1.3B deal and also the 20% holder Patrick Soon-Shiong - this is a $30+ stock in disguise.